AACR 2026 Special Report: An In-Depth Review of Medicilon’s Three Technical Posters | Bilingual

Preclinical CRO

The AACR Annual Meeting convenes leading cancer experts in San Diego, California, from April 17-22, 2026. Medicilon, with over 20 years of preclinical CRO experience, is represented by Dr. Qingcong Lin, Dr. Mingfeng Bai, and Dr. Steven Zhang. The team is presenting three technical posters highlighting Medicilon’s integrated solutions in conjugate drug analysis, autoimmune CAR-T evaluation models, and end-to-end AOC/RNAi drug […]

AACR 2026

Friday, April 17, 2026,
to Wednesday, April 25, 2026

Search Medicilon

Preclinical CRO

ACS Fall 2026

Preclinical CRO

【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026

Preclinical CRO

World’s First Phase III Positive B7-H3 ADC: Medicilon Congratulates MediLink Therapeutics on NDA Acceptance of Icontamrotamab

Contact Medicilon

Name(Required)
Address(Required)